PTEN公司
PI3K/AKT/mTOR通路
蛋白激酶B
癌症研究
泛素连接酶
信号转导
泛素
细胞生长
细胞生物学
化学
生物
生物化学
基因
作者
Yuanming He,Xiumin Zhou,Shuoyi Jiang,Zu-bin Zhang,Biyin Cao,Jin-bao Liu,Yuanying Zeng,Jun Zhao,Xinliang Mao
标识
DOI:10.1038/s41401-021-00662-z
摘要
The PTEN/AKT/mTOR signaling pathway is frequently dysregulated in non-small cell lung cancer (NSCLC), but the mechanisms are not well-understood. The present study found that the ubiquitin ligase TRIM25 is highly expressed in NSCLC tissues and promotes NSCLC cell survival and tumor growth. Mechanistic studies revealed that TRIM25 binds to PTEN and mediates its K63-linked ubiquitination at K266. This modification prevents the plasma membrane translocation of PTEN and reduces its phosphatase activity therefore accumulating PI(3,4,5)P3. TRIM25 thus activates the AKT/mTOR signaling. Moreover, we found that the antibacterial nitroxoline can activate PTEN by reducing its K63-linked polyubiquitination and sensitizes NSCLC to cisplatin-induced apoptosis. This study thus identified a novel modulation on the PTEN signaling pathway by TRIM25 and provides a potential target for NSCLC treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI